MedPath
NMPA Approval

Bendamustine Hydrochloride for Injection

国药准字HJ20180087

August 1, 2023

H20180087

Drug Information

注射用盐酸苯达莫司汀

存达

注射剂

100mg(以C₁₆H₂₁Cl₂N₃O₂·HCl计)

化学药品

August 1, 2023

July 31, 2028

Company Information

Applicant Company

Cephalon LLC

145 Brandywine Parkway, W Chester, PA 19380,United States of America

Manufacturing Company

Pharmachemie B.V.

Swensweg 5, Haarlem 2031 GA Netherlands

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

注射用盐酸苯达莫司汀 - NMPA 批准文号 | MedPath